Clinical Trial Update: Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI) [Phase 3]

View source ↗

Summary

Phase 3 trial update on early ibuprofen treatment for patent ductus arteriosus in premature infants (TRIOCAPI) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patent Ductus Arteriosus

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Nantes University Hospital | Conditions: Patent Ductus Arteriosus | Phase 3 | Status: COMPLETED